LIK066 is a synthetic non-steroidal anti-inflammatory drug that acts as a selective COX-2 inhibitor, primarily indicated for managing pain and inflammation associated with conditions such as osteoarthritis… Read more
LIK066 is a synthetic non-steroidal anti-inflammatory drug that acts as a selective COX-2 inhibitor, primarily indicated for managing pain and inflammation associated with conditions such as osteoarthritis and rheumatoid arthritis. This category contains a comprehensive range of reference standards, including LIK066 impurities, degradation products, metabolites, and stable isotope-labelled compounds, which are essential tools for pharmaceutical research and development. Analytical laboratories rely on these high-quality materials for accurate impurity profiling, method validation, and rigorous quality control testing. Furthermore, these compounds are vital for conducting precise pharmacokinetic studies and ensuring the safety and efficacy of the therapeutic agent throughout its lifecycle. By providing consistent and reliable analytical markers, this collection supports the critical requirements of regulatory compliance and the advancement of pharmaceutical analysis.